Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03787498
What this trial is testing

PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Opna Bio LLC 22
Testing effectiveness (Phase 2)Ended earlyNCT00582816
What this trial is testing

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Who this might be right for
LeukemiaSolid Tumors
University of Wisconsin, Madison 9
Large-scale testing (Phase 3)UnknownNCT01484171
What this trial is testing

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 50
Large-scale testing (Phase 3)Study completedNCT00483132
What this trial is testing

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Who this might be right for
Leukemia, Lymphocytic, Acute
French Innovative Leukemia Organisation 232
Testing effectiveness (Phase 2)WithdrawnNCT04100330
What this trial is testing

Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AVEO Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT03041636
What this trial is testing

Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUntreated Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Ended earlyNCT04266301
What this trial is testing

Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals 530
Testing effectiveness (Phase 2)Ended earlyNCT00666497
What this trial is testing

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Mirati Therapeutics Inc. 6
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT02204020
What this trial is testing

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Pittsburgh
Testing effectiveness (Phase 2)Looking for participantsNCT03136146
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic LymphomaRecurrent Burkitt Leukemia+8 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01729091
What this trial is testing

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasma Cell Myeloma
M.D. Anderson Cancer Center 72
Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Not applicableStudy completedNCT04699162
What this trial is testing

Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Christian Omar Ramos-Peñafiel, MD, PhD 56
Early research (Phase 1)Study completedNCT00634504
What this trial is testing

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

Who this might be right for
OsteosarcomaLeukemiaLymphoma
BTG International Inc. 20
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT01841333
What this trial is testing

PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionRecurrent Adult Acute Myeloid Leukemia
University of Colorado, Denver 31
Early research (Phase 1)Ended earlyNCT02846376
What this trial is testing

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hackensack Meridian Health 8
Testing effectiveness (Phase 2)Ended earlyNCT04358458
What this trial is testing

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+5 more
Genmab 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749976
What this trial is testing

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B Cell Lymphoma (DLBCL)High Risk Myelodysplastic Syndrome+2 more
Vitruviae 108
Next Page